To confirm these results, we examined CAPG expression across multiple malignancies in the GEPIA database and found that CAPG levels were also significantly higher in BRCA (breast invasive carcinoma), GBM (glioblastoma multiforme), OV (ovarian serous cystadenocarcinoma), and PAAD (pancreatic adenocarcinoma) when compared to adjacent normal tissues (Figure 1(b)). This evidence concerns the gene CAPG and glioblastoma.